The following is a summary of the FitLife Brands, Inc. (FTLF) Q4 2023 Earnings Call Transcript:

Financial Performance:

• FitLife observed a decline in wholesale revenue due to reduced foot traffic at GNC, their largest customer.

• Their online revenue, however, was positive with growing subscribers.

• FitLife paid over $17 million to acquire Mimi's Rock Corporation (MRC), which saw consistent EBITDA at or over $500,000 a month.

• FitLife's balance sheet is strong with an outstanding term loan of approximately $16.5 million, a reduction of about $4.7 million in Q1.

• They also made an acquisition of MusclePharm in Q4, which had a minimal impact financially as it happened close to the inventory acquisition time.

Business Progress:

• FitLife is focused on growing their online business and is launching new products in 2024.

• They are exploring international wholesale opportunities for augmentation.

• FitLife has secured the full MusclePharm product line back onto iHerb, with sales steadily increasing.

• Termed as the primary seller of MusclePharm products on Amazon, the brand is now listed on NASDAQ to raise its visibility.

• FitLife is restoring MusclePharm's old wholesale channels while working with potential wholesale and distribution partners and maintaining their margins.

• The company plans to launch the Combat Crunch Bar online first before distributing it to wholesalers.

More details: FitLife Brands IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.